AFLAC stock (US0010551028): Japan Post trims stake as shares trade near record highs

AFLAC stock is trading close to its 52?week high while Japan Post Holdings has reported a fresh insider sale of shares. What is driving the insurer’s valuation and how does the core business model look for US-focused investors?

AFLAC stock is drawing attention after a Japan Post Holdings unit reported open-market sales of AFLAC shares while the insurer’s stock trades close to a fresh 52-week high, according to a June 2026 insider filing summarized by StockTitan and coverage from Investing.com.StockTitan as of 06/06/2026Investing.com as of 06/07/2026

The filing indicates that a Japan Post Holdings subsidiary sold around 16,300 AFLAC shares on June 4, 2026, at weighted average prices in the range of roughly 115 to 116 US dollars per share, at a time when the stock was trading close to its 52?week high near 119.81 US dollars.StockTitan as of 06/06/2026Investing.com as of 06/07/2026

According to recent market data, AFLAC shares have been trading above 115 US dollars on the New York Stock Exchange, up over 2% in the last 24 hours at one point, underscoring the insurer’s strong stock-price momentum over the past year.TradingView as of 06/08/2026

As of: 08.06.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: AFLAC Inc.
• Sector/industry: Insurance, supplemental health and life
• Headquarters/country: Columbus, Georgia, United States
• Core markets: United States and Japan
• Home exchange/listing venue: New York Stock Exchange (ticker: AFL)
• Trading currency: US dollar (USD)

AFLAC Inc.: core business model

AFLAC Inc. is best known in the United States for its supplemental insurance products, which are designed to pay cash benefits directly to policyholders to help cover out?of?pocket costs that traditional health or life insurance may not fully reimburse.Aflac company information as of 02/29/2024

The company’s business model centers on voluntary policies sold primarily at the workplace, where employers offer AFLAC coverage as an add?on option that employees can elect and pay for through payroll deductions, giving the insurer access to large pools of potential customers with relatively low distribution costs.Aflac company information as of 02/29/2024

Historically, AFLAC has operated through two major segments, AFLAC Japan and AFLAC U.S., with the Japanese business contributing a significant share of premium income, particularly in life and cancer insurance products tailored to that market’s demographic and healthcare characteristics.Aflac Q4 2023 earnings release as of 02/01/2024

In recent years, AFLAC has emphasized a strategy of disciplined underwriting, conservative investment management and returning capital to shareholders via dividends and share repurchases, aiming to balance growth with financial stability in a heavily regulated insurance landscape.Aflac Q4 2023 earnings release as of 02/01/2024

The company also invests in brand recognition, particularly in the US, where the AFLAC duck advertising campaigns have helped build awareness of supplemental insurance and distinguish the brand from broader health insurers and managed-care companies.Aflac company information as of 02/29/2024

Main revenue and product drivers for AFLAC Inc.

AFLAC’s revenue base is dominated by premium income from supplemental health, life, cancer and accident policies, with the mix differing between Japan and the US but unified by the focus on products that deliver cash benefits when policyholders face illness, injury or other covered events.Aflac Q4 2023 earnings release as of 02/01/2024

In its full?year 2023 results published in February 2024, AFLAC reported net earned premiums and revenues that reflected solid performance in both Japan and the US, while also highlighting the impact of foreign?exchange movements on translated results, given the importance of yen?denominated business.Aflac Q4 2023 earnings release as of 02/01/2024

The insurer’s US segment generates revenue from products such as accident, short?term disability, hospital indemnity, critical illness and dental and vision coverage, which are often sold to employees at small and mid?sized businesses that seek to enhance their benefits packages without bearing the full cost of the policies.Aflac company information as of 02/29/2024

In Japan, AFLAC markets cancer insurance, medical insurance and savings?oriented life insurance policies through distribution channels that include banks, post offices and independent agencies, giving it exposure to a large and aging population that values financial protection against health?related expenses.Aflac Q4 2023 earnings release as of 02/01/2024

AFLAC’s investment portfolio is another important driver of overall results, as premiums collected are invested primarily in fixed?income securities to generate net investment income, subject to interest?rate conditions and credit spreads that can influence earnings and capital levels.Aflac Q4 2023 earnings release as of 02/01/2024

The company has also highlighted digital initiatives and partnerships to streamline enrollment and claims processing, aiming to make it easier for employers and employees to interact with AFLAC, which can support retention and cross?selling of additional products in both core markets.Aflac company information as of 02/29/2024

Industry trends and competitive position

AFLAC operates at the intersection of health and life insurance, a segment that continues to be shaped by rising healthcare costs, aging populations and employer efforts to manage benefit expenses while still offering attractive coverage options to employees.Aflac company information as of 02/29/2024

Within the US insurance landscape, AFLAC’s focus on supplemental coverage rather than major medical plans differentiates it from large health insurers, positioning the company as a provider of financial protection that can complement both employer?sponsored and individual health plans.Aflac company information as of 02/29/2024

In Japan, AFLAC competes with domestic and international life and health insurers but benefits from a long presence, established distribution partnerships and product offerings tailored to local preferences, giving it a notable share in cancer and medical insurance segments.Aflac Q4 2023 earnings release as of 02/01/2024

Macro factors such as interest?rate trends, currency movements between the US dollar and Japanese yen, and regulatory changes in both jurisdictions remain key external drivers that can affect AFLAC’s reported earnings, capital ratios and competitive positioning over time.Aflac Q4 2023 earnings release as of 02/01/2024

Why AFLAC Inc. matters for US investors

For US investors, AFLAC represents exposure to the insurance sector with a significant international component, as its Japanese operations account for a large share of premium volume while its shares are listed and traded in US dollars on the New York Stock Exchange.Aflac Q4 2023 earnings release as of 02/01/2024

The stock’s recent performance, with prices near a 52?week high and short?term gains of around 2% in a single session, reflects how equity markets are currently assessing the company’s earnings power, capital position and shareholder?return policies.TradingView as of 06/08/2026

Because AFLAC focuses on supplemental coverage, its performance may not move in lockstep with broader health insurers that are more exposed to claims volatility in major medical plans, offering a somewhat differentiated risk and return profile within a diversified US financials allocation.Aflac company information as of 02/29/2024

At the same time, the company’s reliance on investment income and yen?denominated cash flows introduces sensitivities to interest?rate cycles and foreign?exchange trends, factors that US investors typically consider when evaluating globally active insurers.Aflac Q4 2023 earnings release as of 02/01/2024

Conclusion

The latest insider sale by a Japan Post Holdings unit comes as AFLAC stock trades close to its 52?week high, underscoring how strongly the market currently values the insurer’s global supplemental insurance franchise.StockTitan as of 06/06/2026Investing.com as of 06/07/2026

AFLAC’s core business relies on supplemental health and life products in the US and Japan, supported by conservative underwriting and an investment portfolio geared toward fixed?income assets, which may appeal to investors seeking exposure to the insurance sector with a cross?border angle.Aflac Q4 2023 earnings release as of 02/01/2024

At the same time, factors such as interest?rate dynamics, currency movements between the US dollar and Japanese yen, regulatory developments and competitive pressures in both markets remain important variables that can influence AFLAC’s earnings trajectory and stock performance over time.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.